Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bromoergocriptin therapy in eumenorrhoic patients presenting galactorrhea

M Gangemi, M Velasco, A Graziottin

    Clinical and Experimental Obstetrics & Gynecology
    |January 1, 1981
    PubMed
    Summary

    Bromocriptine therapy effectively treated hyperprolactinemic patients with galactorrhea. Normoprolactinemic patients showed symptom improvement but less objective and thermographic response to this treatment.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A proof of concept that experience-based management of endometriosis can complement evidence-based guidelines.

    Facts, views & vision in ObGyn·2023
    Same author

    Validation of a clinical tool for vestibular trophism in postmenopausal women.

    Climacteric : the journal of the International Menopause Society·2023
    Same author

    Comment on 'Validation of the diagnosis of mesothelioma and BAP1 protein expression in a cohort of asbestos textile workers from Northern Italy'.

    Annals of oncology : official journal of the European Society for Medical Oncology·2018
    Same author

    Streptococcus salivarius by nasal spray for recurrent otitis: how good is the evidence?

    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2016
    Same author

    Vaginal biological and sexual health--the unmet needs.

    Climacteric : the journal of the International Menopause Society·2015
    Same author

    [Menstruation, inflammation and comorbidities: implications for woman health].

    Minerva ginecologica·2015

    Area of Science:

    • Endocrinology
    • Reproductive Medicine
    • Oncology

    Background:

    • Galactorrhea, a condition of inappropriate milk production, can be associated with elevated prolactin levels.
    • Bromocriptine is a dopamine agonist used to treat hyperprolactinemia.
    • Understanding treatment responses in different prolactin level groups is crucial for clinical management.

    Purpose of the Study:

    • To evaluate the efficacy of Bromocriptine therapy in eumenorrhoic patients with galactorrhea.
    • To compare treatment outcomes between hyperprolactinemic and normoprolactinemic patients.

    Main Methods:

    • Eleven eumenorrhoic patients with galactorrhea received three months of Bromocriptine therapy (2.5 mg/day).
    • Prolactin circadian rhythm was assessed for all patients.

    Related Experiment Videos

  • Mammary condition was evaluated using clinical examination, cytology, and thermography before and after treatment.

    • Main Results:

    • Hyperprolactinemic patients demonstrated significant subjective, clinical, and thermographic improvements.
    • Normoprolactinemic patients experienced notable symptom and galactorrhea improvement.
    • Objective and thermographic responses were less pronounced in normoprolactinemic individuals compared to hyperprolactinemic ones.

    Conclusions:

    • Bromocriptine therapy is effective for galactorrhea in hyperprolactinemic patients.
    • While beneficial for symptoms, Bromocriptine's objective and thermographic impact is less consistent in normoprolactinemic galactorrhea cases.
    • Further research may explore alternative or adjunctive treatments for normoprolactinemic galactorrhea.